tbuckley/cabot-search huggingface dataset:
P1.15-06 Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis
Authors: M. Lorenzi, D. Massa, V. Angerilli, B. Barberio, M. De Ruvo, G. Pretelli, B. Benetti, C. Mulargiu, M.V. Resi, A. Ferro, A. Dal Maso, S. Frega, G. Pasello, V. Guarneri, E.V. Savarino, M. Fassan, L. Bonanno
Journal: Journal of Thoracic Oncology (2022)
EP08.01-074 'Long Responders' Compared to 'Non-Responders' to a First Line Immune Checkpoint Inhibitor in Incurable Non-Small Cell Lung Cancer
Authors: R. Rittberg, B. Leung, A. Shokoohi, Z. Al Hashami, A. Pender, S. Wong, Y. Wang, C. Ho
Journal: Journal of Thoracic Oncology (2022)
EP05.01-034 Sinoatrial Node Radiation Dose Predicts New-Onset Atrial Fibrillation and Mortality in Patients with Lung Cancer Who Undergo Chemoradiotherapy
Authors: K.H. Kim, J. Oh, G. Yang, J. Lee, J. Kim, J.S. Chang, H.I. Yoon
Journal: Journal of Thoracic Oncology (2022)
EP02.03-005 Perioperative Factors That Predict or Are Associated With Prolonged Air Leaks After Robotic-Assisted Pulmonary Lobectomy
Authors: W. West, R.A. Patel, R.L. Gerard, F.O. Velez, C.C. Moodie, J.R. Garrett, J.P. Fontaine, J.R. Tew, J.J. Baldonado, E.M. Toloza
Journal: Journal of Thoracic Oncology (2022)
EP08.01-066 Assessing Immunotherapy in Real Life: Have We Transferred the Increase in Overall Survival in Stage IV NSCLC from Trials to Clinical Practice?
Authors: J.C. Sánchez González, B. Nuñez García, M. Blanco Clemente, V. Calvo de Juan, B. Cantos Sánchez de Ibargüen, M. Méndez García, R. Aguado Noya, D. Ruiz de Domingo, A. González Sánchez, M. Provencio
Journal: Journal of Thoracic Oncology (2022)
P2.07-01 Deep-Learning Based Prediction of c-MET Status from Digitized H&amp;E-Stained Non-Small Cell Lung Cancer Tissue Samples
Authors: D. Rajan, R. Egger, B. Rahsepar, D. Fahy, I. Wapinski, B. Glass, A. Mistry, J. Jin, T. Do, D. French
Journal: Journal of Thoracic Oncology (2022)
EP02.03-026 Is Ratio of Surgical Margin to Nodule Size a Prognostic Factor in Stage 1 Adenocarcinoma?
Authors: S. Kahraman Aydın, S. Aydın, H. Yavuz, A. Ozdil, A.G. Ergonul, T.I. Akcam, K. Turhan, A. Cakan, U. Cagirici, T.M. Ergin
Journal: Journal of Thoracic Oncology (2022)
EP05.02-015 Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-small-Cell Lung Cancer: Optimizing Outcomes throughout the Trajectory of Care
Authors: S. Schmid, E.M. Minnella, Y. Pilon, M. Rokah, R. Rayes, S. Najmeh, J. Cools-Lartigue, L. Ferri, D. Mulder, C. Sirois, S. Owen, B. Shieh, L. Ofiara, A. Wong, S. Sud, G. Baldini, F. Carli, J. Spicer
Journal: Journal of Thoracic Oncology (2022)
P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
Authors: H.R. Kim, C. Gridelli, D. Kapur, A. Tufman, E. Felip, V. Velcheti, Y.J. Kim, T.O. Goetze, P. Garrido Lopez, R. Corre, K. Penkov, R. Anjum, B. Di Pace, W. Liu, T. Borgovan, D. Ledger, J. Carver, A. Waszak, A. Dhar, S. Novello
Journal: Journal of Thoracic Oncology (2022)
EP07.01-024 Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma
Authors: S. Rovers, C. Merlin, S. Fisher, A. Nowak, P. Pauwels, F. Lardon, J. van Meerbeeck, E. Smits, E. Marcq
Journal: Journal of Thoracic Oncology (2022)
OA04.06 PEMbrolizumab Plus Lenvatinib In Second And Third Line Malignant Pleural MEsotheLiomA Patients: A Single Arm Phase II Study (PEMMELA)
Authors: L.-A.H. Douma, C.J. de Gooijer, V.v.d. Noort, F. Lalezari, J.F. de Vries, M. Vermeulen, B. Schilder, I. Smesseim, P. Baas, J.A. Burgers
Journal: Journal of Thoracic Oncology (2022)
P1.14-02 Implantable Cytokine Factories for Eradication of Malignant Pleural Mesothelioma (MPM) Tumors in Mice
Authors: A. Nash, S. Aghlara-Fotovat, B. Castillo, A. Hernandez, A. Pugazenthi, H.-J. Jang, H.-S. Lee, B. Burt, R. Ghanta, O. Veiseh
Journal: Journal of Thoracic Oncology (2022)
EP08.01-059 Safety, Tolerability and Clinical Activity of Selinexor in Combination with Pembrolizumab in Metastatic Non-small Cell Lung Cancer
Authors: M. Altan, J. Tu, D.R. Milton, B. Yilmaz, F.V. Fossella, F.E. Mott, G.R. Blumenschein, B.A. Stephen, D.D. Karp, A. Naing
Journal: Journal of Thoracic Oncology (2022)
P2.08-06 Patient Involvement in Decision-Making around Their Treatment and Care: Findings from a Global Patient Experience Survey
Authors: J. Fenemore, W. Boerckel, M. Rigney, A. McNamara, B. Gaspar, J. Mayans, M. Hennink, J. Fox, L. Pretorius, M. Daniels, S. Winstone, R. Thakrar
Journal: Journal of Thoracic Oncology (2022)
EP05.01-003 First Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy in Asia Area
Authors: C. Kuo, T.-Y. Yang, C.-C. Wang, C.C. Hua, T.-C. Hsia, C.-L. Chiang, J.-C. Ko, C.-L. Tsai, P.-L. Su, J. Su, C.-C. Ho, G.-C. Chang
Journal: Journal of Thoracic Oncology (2022)
P2.08-02 Burning the Candle at Both Ends-Sleep Quality Before and After Chemotherapy in Lung Cancer Patients - A Systematic Review and Meta-Analysis
Authors: A.T. Jeklin, M. Alamgeer, R.G. Stirling, J. Maccora, R. Kumarahuru, D. Paul, A. Afsana, J.F. Wiley
Journal: Journal of Thoracic Oncology (2022)
EP05.01-017 Exploring the Benefits of Adaptive Radiotherapy in NSCLC-patients
Authors: M. Tvilum, C.M. Lutz, A. Khalil, M. Alber, M.I. Holt, M. Kandi, H.H. Schmidt, A. Appelt, M.M. Knap, L. Hoffmann, D.S. Møller
Journal: Journal of Thoracic Oncology (2022)
P1.10-04 Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
Authors: N.S. Mccall, H.S. McGinnis, J.R. Janopaul-Naylor, A.H. Kesarwala, S. Tian, W.A. Stokes, J.W. Shelton, C.E. Steuer, J.W. Carlisle, T. Leal, S.S. Ramalingam, J.D. Bradley, K.A. Higgins
Journal: Journal of Thoracic Oncology (2022)
EP07.02-001 Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker
Authors: B. Mosleh, K. Schelch, T. Klikovits, K. Sinn, K. Hoetzenecker, B. Dome, M. Jakopovic, M.A. Hoda, M. Grusch
Journal: Journal of Thoracic Oncology (2022)
EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)
Authors: A. Leonetti, R. Minari, L. Boni, L. Gnetti, P. Bordi, M. Verzè, L. Ampollini, F. Gelsomino, L. Toschi, F. Cecere, S. Pilotto, G. Metro, F. Passiglia, D. Cortinovis, G. Guaitoli, G. Pasello, A. Delmonte, F. Mazzoni, E. Bria, D. Galetta, C. Genova, D. Rocco, H. Soto Parra, A. Bearz, M.R. Migliorino, A. Camerini, M. Tognetto, M. Tiseo
Journal: Journal of Thoracic Oncology (2022)
EP04.01-001 Prevalence And Outcomes of EGFR Exon 20 Insertion Mutation In NSCLC: Princess Margaret Cancer Center Experience
Authors: A. Mittal, K. Hueniken, S. Cheng, L.J. Zhan, C. Brown, V. Mai, J. Lee, O.O. Adewole, J. Herman, A. Sabouhanian, E. Storm, M.T. Chowdhury, A. Moore, P. Walia, T. Hoxha, J. Parker, D. Patel, K. Balantaram, K. Khan, M. Garcia, S. Schimd, A.G. Sacher, P.A. Bradbury, F.A. Shepherd, N.B. Leighl, G. Liu
Journal: Journal of Thoracic Oncology (2022)
EP01.05-008 Pre-Trial Validation of a Risk Prediction Model for Pulmonary Nodules Trained on a Nested Case-Control Study with No External Cohort
Authors: M.N. Kammer, H. Chen, K. Patel, S.-C. Chen, A. Balar, D. Lakhani, S. Mahapatra, B. Landman, S. Deppen, E. Grogan, F. Maldonado, A. Baron
Journal: Journal of Thoracic Oncology (2022)
EP03.01-010 Clinicopathological Characteristics of Non-Small Cell Lung Cancer patients in the United Arab Emirates and Correlation with Their Outcomes
Authors: F. Azribi, A. Yousif, J. Ansari, E. Dawoud, D. Trad, K. Al Qawasmeh, A. Al-Awadhi, L. Kurban, M. Hourani, M. Ahmed, O. El-Koha, S. Magdub, A. Elkkari, M. Al Baloushi, E. Black, N. Bennini, K. Balaraj, A. Gargoum
Journal: Journal of Thoracic Oncology (2022)
EP05.02-013 Immune-Related Adverse Effects and Durvalumab Treatment Patterns in VHA Patients with Unresectable Stage III NSCLC
Authors: A. Moore, Z. Nooruddin, K.R. Reveles, P. Datta, L. Brannman, I. Cotarla, A. Frankart, T. Mulrooney, X. Jones, C.R. Frei
Journal: Journal of Thoracic Oncology (2022)
EP02.02-007 Correlation between Biological Equivalent Dose and Radiological Changes after Lung Stereotactic Ablative Radiation Therapy
Authors: C. Cases Copestake, M. Benegas, M. Sánchez González, I. Vollmer Torrubiano, F. Casas Duran, C. Gomà, M. Mollà
Journal: Journal of Thoracic Oncology (2022)
OA03.07 Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial
Authors: S. Lu, H. Jian, Y. Zhang, Z. Song, Y. Zhao, P. Wang, L. Jiang, Y. Gong, J. Zhou, X. Dong, N. Yang, J. Fang, W. Zhuang, S. Cang, R. Ma, J. Shi, P. Wu, J. Lu, Z. Xiang, Z. Shi, L. Zhang, Y. Wang
Journal: Journal of Thoracic Oncology (2022)
EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer
Authors: L. Corke, J. Laskin, J. Agulnik, S. Laurie, D. Hao, R. Juergens, R. Fernandes, L. Le, J. Law, D. Ezeife, A. Shookoohi, G. Kasymjanova, S. Kelly, T. Nadon, R. Lanman, L. Kiedrowski, N. Leighl
Journal: Journal of Thoracic Oncology (2022)
EP05.02-005 Is Immunotherapy Safer Than Radiotherapy in Combination With Chemotherapy in Neoadjuvant Therapy?
Authors: E. Cesur, K.B. Ozer, S. Erus, P. Bulutay, F. Selcukbiricik, S. Tanju, P. Firat, N. Molinas Mandel, S. Dilege
Journal: Journal of Thoracic Oncology (2022)
EP01.05-004 Trial in Progress: An Observational Study for Management of Lung Nodules across Latin America (DOuBLED Study)
Authors: F. Da costa, S. Lamot, L. Viola, L. Noriega-Aguirre, J.F. Corona-Cruz, D. Lopes, S. Goncalves, L. Ramirez, F. Reinhold
Journal: Journal of Thoracic Oncology (2022)
P2.09-03 A Radiomics Approach Using Baseline CT Can Predict Response to 1st-Line Pembrolizumab in Advanced NSCLC with High PD-L1
Authors: R. Yuan, I. Jazen, C. Ho, B. Melosky, J. Li, S. Lam, C. MacAulay
Journal: Journal of Thoracic Oncology (2022)
EP08.01-012 First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience
Authors: B. Benetti, A. Ferro, F. Girardi, L. Calvetti, A. Pavan, C. Mulargiu, F. Simionato, G. Pretelli, M. Lorenzi, M.V. Resi, G. Marinato, A. Dal Maso, S. Frega, G. Pasello, G. Aprile, P. Morandi, V. Guarneri, L. Bonanno
Journal: Journal of Thoracic Oncology (2022)
EP08.01-023 Factors Associated with Survival and Refusal of Physician Recommended Immunotherapy in Metastatic Non Small Cell Lung Cancer
Authors: I.S. Jabbal, D. Saravia, C. Rivera, M. Yaghi, B. Dominguez, V. Henry, H. Liang, Z. Nahleh, E. Alley, R. Arteta-Bulos
Journal: Journal of Thoracic Oncology (2022)
EP03.01-014 Results From the BEWELL Study: Black Raspberry Nectar for the Prevention of Lung Cancer (NCT04267874)
Authors: M. BIttoni, A. Bibi, C. Wheeler, N. Williams, R. Hoyd, K. Heitman, M. Webb, E. Grainger, K. Riedl, F. Tabung, Y. Vodovotz, D. Carbone, S. Clinton, D. Spakowicz
Journal: Journal of Thoracic Oncology (2022)
EP08.01-064 Serum NY-ESO-1 and XAGE1 Antibodies Predict and Monitor Clinical Responses to Immune Checkpoint Therapy for NSCLC
Authors: M. Oka, K. Kurose, K. Sakaeda, M. Fukuda, Y. Sakai, Y. Atarashi, K. Shimizu, T. Masuda, K. Nakatomi, S. Kawase, T. Suetsugu, K. Mizuno, S. Takemoto, H. Yamaguchi, H. Inoue, N. Hattori, M. Nakata, H. Mukae, T. Oga
Journal: Journal of Thoracic Oncology (2022)
P1.10-01 Phase 3 Study of Durvalumab Combined with Oleclumab or Monalizumab in Patients with Unresectable Stage III NSCLC (PACIFIC-9)
Authors: F. Barlesi, S.B. Goldberg, H. Mann, A. Gopinathan, M. Newton, C. Aggarwal
Journal: Journal of Thoracic Oncology (2022)
P2.10-02 EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer
Authors: P. Bushunow, S. Dakhil, P. Lammers, N. Naveh, A. Boccuti, R. Hanvesakul, W. Li, J. Migas, D. Slater, F. Badin, B. Halmos
Journal: Journal of Thoracic Oncology (2022)
P2.12-03 External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients with Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
Authors: L. Dercle, D. Gomez, B. Zhao, K. Kelly, R.S. Herbst, M.W. Redman, D.R. Gandara, L.H. Schwartz
Journal: Journal of Thoracic Oncology (2022)
EP04.01-027 Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis
Authors: V.S. Tan, M.C. Tjong, W.C. Chan, M. Yan, V. Delibasic, G. Darling, L.E. Davis, M. Doherty, J. Hallet, B. Kidane, A. Mahar, N. Mittmann, A. Parmar, H. Tan, F.C. Wright, N.G. Coburn, A.V. Louie
Journal: Journal of Thoracic Oncology (2022)
OA13.04 Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study
Authors: M. Garcia, M. Garcia de Herreros, E. Auclin, G. Caravaca, J. Sart, M. Riudavets, D. Vasseur, V. Albarran-Artahona, J.C. Laguna, T. Gorria, R. Lopez Castro, C. Teixido, G. Castellano, A. Bedmar Martinez, A. Arcocha, N. Vinolas, R. Reyes, A. Prat, N. Reguart, J. Elio, N. Leighl, B. Besse, L. Mezquita
Journal: Journal of Thoracic Oncology (2022)
EP08.01-026 Influence of Brain Metastases on Survival of KRASG12C Mutated Stage IV Immune Checkpoint Inhibitor Treated Non-Small Cell Lung Cancer Patients
Authors: E. Swart, A.L. Noordhof, R.A.M. Damhuis, P.W.A. Kunst, D.K.M. De Ruysscher, L.E.L. Hendriks, W.H. van Geffen, M.J. Aarts
Journal: Journal of Thoracic Oncology (2022)
OA15.04 Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC
Authors: S. Peters, B.C. Cho, A. Luft, J. Alatorre-Alexander, S.L. Geater, S.-W. Kim, G. Ursol, M. Hussein, F.L. Lim, C.-T. Yang, L.H. Araujo, H. Saito, N. Reinmuth, R. Stewart, Z. Lai, R. Doake, L. Krug, E.B. Garon, T. Mok, M.L. Johnson
Journal: Journal of Thoracic Oncology (2022)
P1.04-03 Independent Validation of the Maisonneuve Lung Cancer Risk Model to Optimize Screening Interval in High-risk Individuals
Authors: P. Maisonneuve, M. Casiraghi, R. Bertolotti, C. Rampinelli, P. Muriana, L. Spaggiari, G. Veronesi
Journal: Journal of Thoracic Oncology (2022)
EP02.01-001 Plasma Cell-Free DNA as a Point-of-Care Wellbeing Biomarker for Early-Stage Non-Small Cell Lung Cancer Patients
Authors: A.L. McGuire, S. Sharma, R.A. Hilzenrat, M.K. McConechy, I.R. Frank, C. Hughesman, S. Yip, J.J. Choi, J. Yee
Journal: Journal of Thoracic Oncology (2022)
EP02.01-008 Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
Authors: M. Zacharias, S. Konjic, G. Absenger, M.J. Hochmair, H. Fabikan, C. Weinlinger, O. Illini, P.J. Jost, V. Schlintl, R. Wurm, J. Lindenmann, M. Fediuk, L. Brcic, A. Terbuch
Journal: Journal of Thoracic Oncology (2022)
EP05.01-018 Chemoradiotherapy Followed by Durvalumab in Unresectable Locally Advanced NSCLC- A Single Institution Experience in Croatia
Authors: A. Bacelic Gabelica, F. Seiwerth, L. Bitar, D. Srdić, O. Maletić, S. Pleština, M. Samaržija, M. Jakopović
Journal: Journal of Thoracic Oncology (2022)
P1.06-01 Adjuvant Osimertinib vs Placebo in Completely Resected Stage IA2-IA3 EGFR-mutated NSCLC: The ADAURA2 Phase III Study
Authors: J. Goldman, Y. Tsutani, S. Dacic, Y. Yatabe, M. Majem, X. Huang, A. Chen, T. Van der Gronde, J. He
Journal: Journal of Thoracic Oncology (2022)
P2.04-03 Perceptions and Knowledge of Electronic Smoking Devices among Patients with Solid Tumors and their Care-Givers
Authors: V. Bianco, D. Dellerba, M. Gianetta, B. Innocenti, C. Paratore, C. Cecchi, E. Parlagreco, M. Bungaro, C. Damiano, P. Bironzo
Journal: Journal of Thoracic Oncology (2022)
EP04.01-002 Costs of Locoregional and Metastatic Recurrences in Patients with Resectable Stage II-III NSCLC in Spain
Authors: J.d.C. Carpeño, A. Insa, R. Collado, V. Escudero, A. Martínez, E. Fernandez, I. Sullivan, L. Crama, N. Arrabal, D. Carcedo, A. Manzaneque
Journal: Journal of Thoracic Oncology (2022)
EP02.01-006 Advances in the Treatment of Postoperative Recurrence of Non-Small Cell Lung Cancer and Their Real-World Impact on Survival
Authors: K. Hashimoto, R. Ariyasu, J. Ichinose, Y. Matsuura, M. Nakao, Y. Amino, K. Uchibori, S. Kitazono, N. Yanagitani, S. Okumura, M. Nishio, M. Mun
Journal: Journal of Thoracic Oncology (2022)
EP07.01-022 Analysis of Second Surgery for Recurrence in Malignant Pleural Mesothelioma (MPM) Patients (P)
Authors: S. Cedres, L. Romero, J.D. Assaf, P. Iranzo, A. Callejo, N. Pardo, A. Navarro, A. Martinez-Marti, G. Molina, D. Garcia-Illescas, L. Sanchez, J. Rosado, C. Carbonell, J. Frigola, R. Amat, J. Gonzalo, V. Navarro, R. Dienstmann, E. Felip
Journal: Journal of Thoracic Oncology (2022)
OA14.06 T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing
Authors: F. Oezkan, S. Hilz, J. Grindheim, A. Wallace, M. Seweryn, A. Reuben, J. Zhang, D.H. Owen, A. Nicholas, M. Yadav, D. Nagarkar, P. de Almeida, P. Ebert, E. Osborne, A. Johnson, J.M. Lee, P. Bunn, B.E. Johnson, J. Chaft, M.G. Kris, V.W. Rusch, K. Schulze, D.J. Kwiatkowski, I.I. Wistuba, D.P. Carbone
Journal: Journal of Thoracic Oncology (2022)
EP07.01-014 Mesothelioma-Associated Fibroblasts Enhance Mesothelioma Aggressiveness and Modulate Drug Response
Authors: A. Ries, D. Flehberger, K. Schelch, C. Pirker, M.A. Hoda, W. Berger, M. Grusch
Journal: Journal of Thoracic Oncology (2022)
EP01.07-006 Incidence and Resource Burden for the Management of CT Detected Ground Glass Opacities at a Tertiary Lung Cancer Service in the UK
Authors: M.A. Ashraf, A. AlShammari, P. De Sousa, V. Naruka, L. Tincknell, S. Booth, C. Proli, A. Patel, C. Docherty, J. Murray, T. Wagner, N. Mhizha, E. Lim
Journal: Journal of Thoracic Oncology (2022)
MA03.09 Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.
Authors: P.S.n. van Rossum, N. Wolfhagen, A.M. van der Wel, L.W. van Bockel, I.E.M. Coremans, A.L.A.J. Dekker, C.A. van Es, K.E.A. de Jaeger, H.P. Knol, M.W. Kolff, F.L.A. Koppe, J. Pomp, D.A.X. Schinagl, F.O.B. Spoelstra, C.J.A. Tissing-Tan, J.F. Ubbels, E.J.A. Vonk, N.C.M.G. van der Voort van Zijp, E.M. Wiegman, A.M. van der Geest, B.J.T. Reymen, D. van Kampen, R.A.M. Damhuis, J.S.A. Belderbos
Journal: Journal of Thoracic Oncology (2022)
P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
Authors: C. Proto, M.V. Chiaruttini, A. Prelaj, G. Lo Russo, R. Ferrara, S. Manglaviti, A. De Toma, M. Brambilla, M. Occhipinti, T. Beninato, L. Mazzeo, C. Pircher, A.D. Dumitrascu, F. de Braud, M. Segale, M.C. Garassino, G. Sozzi, L. Porcu, E. Rulli, M. Boeri
Journal: Journal of Thoracic Oncology (2022)
EP04.01-010 Addressing Barriers to Lung Cancer Care for Diverse Populations through Patient Navigation: The University of Miami Experience
Authors: E. Rodriguez, C. Olazagasti, K. Khan, S. Kareff, T. Torres, S. Torrents, G. Fernandez-Vega Martinez, J. MacIntyre, G. Lopes
Journal: Journal of Thoracic Oncology (2022)
EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)
Authors: A. Horne, S. Brown, K. Butterworth, A. Chalmers, F. Collinson, C. Dive, C. Faivre-Finn, M. Forster, K. Franks, A. Gilbert, M. Hallam, G. Hanna, S. Harrow, J. Hartley, C. Hiley, R. Jones, E. Katona, J. Kendall, M. Krebs, G. Mallison, J.B. Oughton, R. Phillip, D. Rothwell, D. Sebag-Montefiore, P. Shaw, G. Walls, F. Walker, R. Young, A. Greystoke
Journal: Journal of Thoracic Oncology (2022)
P2.02-02 A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy
Authors: R. Millett, M. Shafique, C. Kim, J. Malhotra, E. Bertino, M. Bootsma, J. Schehr, J. Eickhoff, J. Lang, N. Sethakorn, T. Leal
Journal: Journal of Thoracic Oncology (2022)
MA04.05 T3 Defining Features Influence Long Term Survival after Resection of T3N0M0 NSCLC
Authors: P.A. Ugalde Figueroa, E. Marques, V.J. Cilento, D.J. Giroux, K.K. Nishimura, P. Bertoglio, C.-F.J. Yang, W. Fang, Y. Tae Kim, H. Asamura
Journal: Journal of Thoracic Oncology (2022)
P2.07-02 RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
Authors: S. Hernandez, J.L. Rodriguez Carrillo, A. Caminoa, A. Benito, R. Martinez, M. Alonso, S. Clave, E. Arriola, I. Esteban-Rodriguez, J. De Castro, I. Sansano, E. Felip, I. Abdulkader, J. Garcia, F. Rojo, M. Domine, C. Teixido, N. Reguart, D. Compañ, A. Insa, N. Mancheño, S. Palanca, O. Juan, N. Baixeras, E. Nadal, M. Cebollero, A. Calles, P. Martin, C. Salas, M. Provencio, I. Aranda, B. Massuti, L. Lopez-Vilaro, M. Majem, P. Garrido, L. Paz-Ares, F. Lopez-Rios, E. Conde
Journal: Journal of Thoracic Oncology (2022)
EP01.03-012 Acceptability and Feasibility of Lung Cancer Screening in Australia: The View of Key Stakeholders
Authors: R.H. Dodd, A.R. Sharman, J. Rhee, H. Marshall, E. Stone, M.L. Yap, S. McCullough, A. McWilliams, N.M. Rankin
Journal: Journal of Thoracic Oncology (2022)
EP04.01-025 Implementation of Electronic Patient Reported Outcomes in Routine Cancer Care
Authors: A. Girgis, A. Bamgboje-Ayodele, O. Rincones, S. Vinod, S. Avery, J. Descallar, B. Arnold, A. Arnold, V. Bray, I. Durcinoska, N. Rankin, G. Delaney
Journal: Journal of Thoracic Oncology (2022)
EP07.01-023 Family History of Cancer in a Series of Malignant Pleural Mesothelioma (MPM) Patients (P)
Authors: S. Cedres, M. Cruellas, J.D. Assaf, P. Iranzo, A. Callejo, N. Pardo, A. Navarro, A. Martinez-Marti, C. Carbonell, J. Frigola, R. Amat, J. Gonzalo, V. Navarro, R. Dienstmann, J. Balmaña, E. Felip
Journal: Journal of Thoracic Oncology (2022)
P2.15-01 Digital Pathology Uncovers Multi-Omic Hallmarks of Lung Cancer in Histopathology Images
Authors: M. Guramare, S.A. Javed, N. Agrawal, M. Griffin, J. Abel, M. Montalto, A.H. Beck, V. Mountain, I. Wapinski, M. Resnick, C. Biddle-Snead, J.R. Conway
Journal: Journal of Thoracic Oncology (2022)
EP08.01-019 Modifiable biomarkers of response to immune checkpoint inhibitor treatment in non-small cell lung cancer
Authors: D. Spakowicz, N. Williams, A. Bibi, R. Hoyd, C.E. Wheeler, S. Suman, J. Amann, T. Okimoto, M. Grogan, P. Vibhakar, D. Owen, D.P. Carbone, C. Presley
Journal: Journal of Thoracic Oncology (2022)
EP05.02-004 Could Fifty Percent Tumor Viability Be a Good Prognostic Factor?
Authors: S. Erus, E. Cesur, K.B. Ozer, P. Bulutay, F. Selcukbiricik, S. Tanju, P. Firat, N. Molinas Mandel, S. Dilege
Journal: Journal of Thoracic Oncology (2022)
EP02.01-009 PD-L1 Expression in Biopsies and Surgical Specimens of Lung Cancer: Impact of Biopsy Methods and Neoadjuvant Therapy
Authors: M.A. Hoda, K. Sinn, J. Brugger, D. Bernitzky, B. Mosleh, H. Prosch, S. Geleff, K. Hoetzenecker, M. Idzko, D. Gompelmann
Journal: Journal of Thoracic Oncology (2022)
EP07.01-002 Surgery in Stage I-III Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER)- Medicare Analysis 1995-2015
Authors: Q. Wang, N. Alpert, Y. Zhang, J.H. Tran, C. Jiang, X. Wang, J. Gomez, J.P. Wisnivesky, E. Taioli, A. Wolf, R. Veluswamy
Journal: Journal of Thoracic Oncology (2022)
EP04.01-023 Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry (ANZLCR)
Authors: R. Stirling, S. Smith, M. Brand, S. Harden, L. Briggs, L. Leigh, F. Brims, M. Brooke, V. Brunelli, C. Chia, P. Dawkins, R. Lawrenson, M. Duffy, S. Evans, T. Leong, H. Marshall, D. Patel, N. Pavlakis, J. Philip, N. Rankin, N. Singhal, E. Stone, R. Tay, S. Vinod, M. Windsor, G. Wright, D. Leong, J. Zalcberg
Journal: Journal of Thoracic Oncology (2022)
EP07.01-005 Second Primary Cancers in a Population-Based Mesothelioma Registry
Authors: A. D'Aveni, S. Stella, B. Dallari, R. Barile, S. Rugarli, C. Zellino, E. Cerchiaro, L. Riboldi, C. Verusio, D. Consonni, G.L. Ceresoli, C. Mensi
Journal: Journal of Thoracic Oncology (2022)
MA02.09 Impact of Baseline Clinicopathologic and Genomic Features on Outcomes to KRAS G12C Inhibitors in Patients with NSCLC
Authors: G. Lamberti, B. Ricciuti, J.V. Alessi, A.P.C. Barrichello, F. Pecci, V.R. Vaz, L.M. Sholl, M.M. Awad
Journal: Journal of Thoracic Oncology (2022)